Page last updated: 2024-12-08

cholesteryl glucoside

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

cholesteryl glucoside: RN given refers to cpd without isomeric designation [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID440145
CHEMBL ID1170856
CHEBI ID17495
SCHEMBL ID1357529
MeSH IDM0089516

Synonyms (24)

Synonym
cholest-5-en-3beta-yl beta-d-glucopyranoside
(3beta)-cholest-5-en-3-yl d-glucopyranoside
cholesteryl glucoside
cholesterol glucoside
cholesteryl 3-beta-d-glucoside
CHEBI:17495 ,
cholesteryl beta-d-glucoside
C03855
cholesteryl-beta-d-glucoside
(3beta)-cholest-5-en-3-yl-beta-d-glucopyranoside
o-beta-d-glucosyl-cholesterol
(2r,3r,4s,5s,6r)-2-[[(3s,8s,9s,10r,13r,14s,17r)-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-3-yl]oxy]-6-(hydroxymethyl)oxane-3,4,5-triol
CHEMBL1170856
cholesterol glycoside
cholesterol |a-d-glucoside
7073-61-2
SCHEMBL1357529
DTXSID50331472
cholesterol beta-d-glucoside, >=97% (tlc)
cholesteryl-beta-d-galactopyranosid
Q27102427
cholesteryl b-d-glucuronide
cholesterol ??-d-glucoside
AKOS040756197
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
sterol 3-beta-D-glucosideAny beta-D-glucoside derived from a sterol.
monosaccharide derivativeA carbohydrate derivative that is formally obtained from a monosaccharide.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (5)

Assay IDTitleYearJournalArticle
AID539265Antiapoptotic activity against HUVEC cells at 5 ug/ml after 48 hrs by MTT calorimetric assay2010Bioorganic & medicinal chemistry letters, Dec-01, Volume: 20, Issue:23
Cholesterol-derived novel anti-apoptotic agents on the structural basis of ginsenoside Rk1.
AID492140Antioxidant activity assessed as formazan formation induced absorbance changes at 25 ppm at 570 nm at 37 degC for 6 hrs by MTT assay2010Journal of natural products, Jul-23, Volume: 73, Issue:7
An efficient and economical MTT assay for determining the antioxidant activity of plant natural product extracts and pure compounds.
AID539267Antiapoptotic activity against HUVEC cells at 10 ug/ml after 48 hrs by MTT calorimetric assay2010Bioorganic & medicinal chemistry letters, Dec-01, Volume: 20, Issue:23
Cholesterol-derived novel anti-apoptotic agents on the structural basis of ginsenoside Rk1.
AID539264Antiapoptotic activity against HUVEC cells at 5 ug/ml after 24 hrs by MTT calorimetric assay2010Bioorganic & medicinal chemistry letters, Dec-01, Volume: 20, Issue:23
Cholesterol-derived novel anti-apoptotic agents on the structural basis of ginsenoside Rk1.
AID539266Antiapoptotic activity against HUVEC cells at 10 ug/ml after 24 hrs by MTT calorimetric assay2010Bioorganic & medicinal chemistry letters, Dec-01, Volume: 20, Issue:23
Cholesterol-derived novel anti-apoptotic agents on the structural basis of ginsenoside Rk1.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (40)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (10.00)18.7374
1990's5 (12.50)18.2507
2000's9 (22.50)29.6817
2010's17 (42.50)24.3611
2020's5 (12.50)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 16.30

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index16.30 (24.57)
Research Supply Index3.71 (2.92)
Research Growth Index4.83 (4.65)
Search Engine Demand Index10.37 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (16.30)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews4 (10.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other36 (90.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]